Morphine Sulfate 20 MG Extended Release Oral Capsule [Kadian]

Known as: MORPHINE SULFATE 20 mg ORAL CAPSULE, EXTENDED RELEASE [KADIAN], Kadian 20 MG Extended Release Oral Capsule, MS 20 MG Extended Release Oral Capsule [Kadian] 
 
National Institutes of Health

Related topics

Related topics

21 relations
Extended Release Oral CapsuleGelatinKadianMETHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
(More)

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
High-Alert Medications
Buprenorphine Buprenex®, Subutex® Butorphenol Stadol® Codeine Codeine phosphate, codeine sulfate, Tylenol with codeine… (More)
Is this relevant?
2016
2016
Tubercular Appendicitis: A Rare Cause of Acute Abdomen in Children
How to cite this article: Kadian YS, Singh M. Tubercular appendicitis: A rare cause of acute abdomen in children. OGH Reports… (More)
  • figure 1
  • figure 2
Is this relevant?
2011
2011
The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy…
Morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®, King Pharmaceuticals®, Inc., Bristol, TN… (More)
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2007
2007
(758): In vivo pharmacokinetics of KADIAN® (morphine sulfate extended-release) capsules taken with alcohol
 
Is this relevant?
2005
2005
A head-to-head, single-dose trial of KADIAN® vs AVINZA® 30mg in healthy, opioid-naïve subjects in the fed state: Comparison of pharmacokinetics
 
Is this relevant?
2005
2005
Treatment of neuropathic pain with KADIAN® in poor responders to other pain medications
 
Is this relevant?
2004
2004
Opioids in non-cancer pain: Improved quality of life with Kadian® (morphine sulfate sustained-release capsules) in patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
 
Is this relevant?
2004
2004
Opioids in non-cancer pain: Kadian® (morphine sulfate sustained-release capsules) is effective and safe for elderly patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
 
Is this relevant?
2004
2004
Opioids in non-cancer pain: Kadian® (morphine sulfate sustained release-capsules) is safe and well-tolerated in patients with chronic, non-malignant, moderate/severe pain: The KRONUS-MSP trial
 
Is this relevant?
1997
1997
Comparison of a once-a-day sustained-release morphine formulation with standard oral morphine treatment for cancer pain.
Kadian/Kapanol (K) is a capsule formulation of morphine designed for 12- or 24-hourly dosing. This double-blind study compared… (More)
Is this relevant?